NEKTAR THERAPEUTICS (NKTR:NASDAQ)
$39.84 -1.33 (-3.2305%)
Analysed NEKTAR THERAPEUTICS (NKTR:NASDAQ) News Sources
New Biomarker Data Presented in a Late Breaking Oral Presentation at EADV Congress 2026 Showing Early Molecular Responses to Rezpegaldesleukin Across Multiple Immune Pathways Dysregulated in Patients with Atopic Dermatitis
30-09-2026
yahoo.com
/UPDATE -- Nektar Therapeutics/
01-10-2026
yahoo.com
3 Biotech Stocks Put Traders Are Targeting Today
01-10-2026
yahoo.com
Nektar REZPEG Data Show Durable Hair Regrowth, Set Up Phase III Alopecia Trial
01-10-2026
marketbeat.com
This Biotech Had Good News for Hair Loss Sufferers. So Why Is the Stock Sinking?
01-10-2026
yahoo.com
NKTR Stock Eyes Worst Day In Over 3 Years On Rezpeg Data: William Blair Still Sees A Durability Edge
01-10-2026
stocktwits.com
Nektar Posted Promising Alopecia Results. Here's Why It Took A 22% Beating.
01-10-2026
yahoo.com
EADV26: Key late-stage readouts from the conference
05-10-2026
clinicaltrialsarena.com
Nektar Therapeutics (NKTR): $115 Million Lawsuit Victory Over Eli Lilly Clears Multi-Year Overhang
07-10-2026
yahoo.com
Nektar Therapeutics (NKTR) Could Be 71% Undervalued As Rezpegaldesleukin Data Extend Its Case
12-10-2026
yahoo.com
What is the current price of NEKTAR THERAPEUTICS (NKTR:NASDAQ)?
The current price of NEKTAR THERAPEUTICS (NKTR:NASDAQ) is $39.84.
NEKTAR THERAPEUTICS (NKTR:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEKTAR THERAPEUTICS (NKTR:NASDAQ) since the previous trading day is $-1.33.
NEKTAR THERAPEUTICS (NKTR:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEKTAR THERAPEUTICS (NKTR:NASDAQ) since the previous trading day is -3.2305%.
What is the most recent average sentiment score for NEKTAR THERAPEUTICS (NKTR:NASDAQ)?
The most recent average sentiment score for NEKTAR THERAPEUTICS (NKTR:NASDAQ) is 55 out of 100.
What is the most recent average sentiment for NEKTAR THERAPEUTICS (NKTR:NASDAQ)?
The most recent sentiment for NEKTAR THERAPEUTICS (NKTR:NASDAQ) is .
SEC-8K** Filing Available For NEKTAR THERAPEUTICS (NKTR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.